retatrutide phase 2 trial obesity nejm 2023 Another Promising Medication (Retatrutide) for GLP-1 Receptor Agonists | New

Semaglutide activates GLP-1 receptors in the brain to regulate appetite and blood sugar, but the timeline for noticing results varies by individual

FDA-approved injectable GLP-1 medications include: Semaglutide (Ozempic 0.5-2 mg weekly for diabetes

Medical guidelines advise stopping GLP-1 drugs at least one or two months before pregnancy, and our study cannot on its own change such recommendations, said Dr

Studies suggest that hair loss affects approximately 1 in 20 people taking GLP-1 medications, and while it is often temporary, it can be deeply distressing

Some estimates suggest up to 25% of adults have some level of needle anxiety, which makes a daily drop or a patch sound like an easier alternative

See how it works, dosage, side effects, and how to get started